Counterpoint Mutual Funds’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-34,581
Closed -$2.64M 427
2025
Q2
$2.64M Buy
34,581
+5,257
+18% +$378K 0.23% 12
2025
Q1
$2.05M Buy
29,324
+23,371
+393% +$1.62M 0.29% 19
2024
Q4
$364K Buy
5,953
+1,450
+32% +$94.8K 0.05% 177
2024
Q3
$267K Buy
+4,503
New +$247K 0.05% 168
2024
Q2
Sell
-10,820
Closed -$668K 273
2024
Q1
$668K Buy
10,820
+4,819
+80% +$278K 0.16% 26
2023
Q4
$286K Buy
+6,001
New +$243K 0.11% 21
2023
Q2
Sell
-4,180
Closed -$109K 422
2023
Q1
$109K Sell
4,180
-1,591
-28% -$43.1K 0.1% 187
2022
Q4
$150K Buy
+5,771
New +$158K 0.16% 97

Other funds holding NTNX

Counterpoint Mutual Funds's NTNX Position: Q3 2025 in Review

Counterpoint Mutual Funds sold out of Nutanix (NTNX) in Q3 2025, closing a stake of 34,581 shares — an estimated $2.64M sold.

Counterpoint Mutual Funds first reported a position in NTNX in Q4 2022 and held it in 8 quarters. The position peaked at $2.64M in Q2 2025. 620 funds tracked by Wall St. Rank hold NTNX as of Q3 2025.

  • Counterpoint Mutual Funds reported no remaining Nutanix position as of Q3 2025 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 34,581 Nutanix shares in Q3 2025, an estimated $2.64M.
  • Counterpoint Mutual Funds first reported a position in Nutanix in Q4 2022 and held it in 8 quarters.
  • Counterpoint Mutual Funds's Nutanix position peaked at $2.64M in Q2 2025.
  • 620 funds tracked by Wall St. Rank held Nutanix as of Q3 2025.

Based on Counterpoint Mutual Funds's 13F filing for Q3 2025, filed 10 Nov 2025.